Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
10,356
datasets available to search
ShareScore release 0.9.0
Dataset results
10,356 results for “Severity”
A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD
ClinicalTrials.gov study NCT03836677. IPD Sharing: Not stated. Countries: 2. Publications: 1.
An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT01009281. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
ClinicalTrials.gov study NCT02531126. IPD Sharing: Not stated. Countries: 20. Publications: 6.
Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis
ClinicalTrials.gov study NCT02785185. IPD Sharing: YES. Countries: 1. Publications: 1.
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
ClinicalTrials.gov study NCT03526861. IPD Sharing: NO. Countries: 10. Publications: 4.
Impact of Acthar on Everyday Life of Participants With Severe Keratitis
ClinicalTrials.gov study NCT04169061. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia
ClinicalTrials.gov study NCT04369469. IPD Sharing: YES. Countries: 5. Publications: 5.
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
ClinicalTrials.gov study NCT03611751. IPD Sharing: Not stated. Countries: 16. Publications: 6.
Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy
ClinicalTrials.gov study NCT01675882. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
ClinicalTrials.gov study NCT00409682. IPD Sharing: Not stated. Countries: 8. Publications: 3.
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of GS-5745 (Andecaliximab) in Adults With Moderate to Severe Active Ulcerative Colitis
ClinicalTrials.gov study NCT01831427. IPD Sharing: Not stated. Countries: 7. Publications: 0.
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
ClinicalTrials.gov study NCT03980483. IPD Sharing: YES. Countries: 10. Publications: 1.
A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3)
ClinicalTrials.gov study NCT03556202. IPD Sharing: YES. Countries: 19. Publications: 1.
PK Study in Subjects With Severe Hepatic Impairment
ClinicalTrials.gov study NCT03664544. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Efficacy and Safety of LAS 34273 in Patients With Moderate to Severe Stable Chronic Obstructive Pulmonary Disease(COPD)
ClinicalTrials.gov study NCT00358436. IPD Sharing: Not stated. Countries: 7. Publications: 1.
Oral DS107 in Moderate to Severe Atopic Dermatitis
ClinicalTrials.gov study NCT02211417. IPD Sharing: Not stated. Countries: 2. Publications: 5.
Comparison of Biologicals in Treatment of Severe Asthma
ClinicalTrials.gov study NCT04158050. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)
ClinicalTrials.gov study NCT03823391. IPD Sharing: YES. Countries: 7. Publications: 1.
Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3
ClinicalTrials.gov study NCT03363854. IPD Sharing: NO. Countries: 8. Publications: 5.
A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis
ClinicalTrials.gov study NCT03443024. IPD Sharing: YES. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.